Wilson Sonsini Goodrich & Rosati is pleased to support LaunchBio’s Larger Than Life Science: Everything is Fine: Clinical Drug Development During a Pandemic.  With the onset of COVID-19 some regulations changed, some clinical trials are canceled, and new FDA guidelines have been implemented. With all these changes, how can companies conduct their clinical trials?

Amanda Gentile of Nocion Therapeutics and Aernout van Haarst of Celerion will discuss the new rules for clinical trials both in and out of the COVID-19 space. They will explain why a company needs to think out of the box in their clinical trial design, adapt, and mitigate risk.